VIEW SELECTED MEDIA

Name of Media:

Author(s):

Publisher or Source:

Type of Media:

COVID-19 Related

Description:

If Media is a PDF or Document, Such as an Article or Chart, Click Icon:

If Media is a Video, Click Icon:

DELIRIUM MANAGEMENT IN THE ICU

the Department of Surgical Education

Orlando Regional Medical Center

Medical Professional Education

Media Originally for:

Critical Care Physicians, Nurses and/or Other Critical Care Medical Professionals

No

Delirium has been previously described as a syndrome of organ dysfunction involving the central nervous system. The prevalence of delirium in the ICU varies from 20-80%. Delirium has been associated with increased hospital length of stay, duration of mechanical ventilation, and mortality. Sedative and narcotic use has been shown to increase the risk and severity of delirium. Haloperidol is the mainstay of delirium management as recommended by the Society of Critical Care Medicine (SCCM) due to extensive clinical experience with this medication. However, its usage is often limited by safety concerns. Atypical antipsychotics such as quetiapine have been shown to have equivalent success in the treatment of delirium while being associated with fewer side effects.

PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.

© 2020 by PostICU, Inc.., a 501(c)3 Corporation All rights reserved. Terms of Service (General), Cookies PolicyTerms of Service for Mobile AppDisclaimers & Disclosures and Privacy Policy.